Contract HHSO100201600023C
Regeneron Pharmaceuticals Inc · Department Of Health And Human Services · August 12, 2016
Regeneron Pharmaceuticals Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on August 12, 2016 for $8.60 million of work in research and development in biotechnology. Performance is in Tarrytown, NY. It was awarded under full and open competition. The contract has been modified 6 times since the base award It uses cost-plus contract pricing. The most recent modification was on March 19, 2026.
Contract details
- PIID
- HHSO100201600023C
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- Tarrytown, NY
- First action
- August 12, 2016
- Latest action
- March 19, 2026
Description
REGENERON ANTI-MERS ANTIBODY THERAPEUTICS PROGRAM DEVELOPMENT
Modification timeline
-
March 19, 2026Mod P00006$-337.5K
-
September 27, 2019Mod P00005THE PURPOSE OF THIS MODIFICATION 5 (FIVE) TO THE CONTRACT IS TO ACCOMPLISH THE FOLLOWING: 1.) EXTEND THE PERIOD OF PERFORMANCE, AT NO ADDITIONAL COST TO THE GO$0
-
June 28, 2017Mod 4IGF::OT::IGF$0
-
January 12, 2017Mod 3IGF::OT::IGF$0
-
November 23, 2016Mod 2IGF::OT::IGF$7.16M
-
August 19, 2016Mod 1IGF::OT::IGF$0
-
August 12, 2016Base awardIGF::OT::IGF$1.78M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| University Of Illinois | Department Of Health And Human Services | March 26, 2026 | $2.27M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 25, 2026 | $9.65M |
| University Of Texas Medical Branch At Galveston | Department Of Health And Human Services | March 23, 2026 | $1.61M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.23M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.22M |
| Transnetyx, Inc | Department Of Health And Human Services | February 26, 2026 | $4.1K |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Alliance For Energy Innovation, Llc | 2 | $10.68B |
| 2 | Emergent Product Development Gaithersburg Inc. | 7 | $1.63B |
| 3 | Janssen Pharmaceuticals, Inc. | 2 | $1.05B |
| 4 | Regeneron Pharmaceuticals Inc | 4 | $1.01B |
| 5 | Siga Technologies, Inc. | 3 | $560.59M |
| 6 | Battelle National Biodefense Institute, Llc | 106 | $469.31M |
| 7 | Glaxosmithkline, Llc | 6 | $321.65M |
| 8 | Merck Sharp & Dohme Llc | 3 | $309.72M |
| 9 | Sri International | 130 | $258.61M |
| 10 | American Type Culture Collection | 7 | $243.18M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSO100201600023C?
Contract HHSO100201600023C is a federal contract awarded to Regeneron Pharmaceuticals Inc by Department Of Health And Human Services on August 12, 2016 for $8.60 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 6 times since the base award.
Who won contract HHSO100201600023C?
Regeneron Pharmaceuticals Inc won contract HHSO100201600023C from Department Of Health And Human Services.
How much is contract HHSO100201600023C worth?
Contract HHSO100201600023C has obligated $8.60 million to date, with a total potential value of $10.76 million if all options are exercised.